![Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease | SpringerLink Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.2165%2F00003495-200969050-00004/MediaObjects/40265_2012_69050549_Fig1.jpg)
Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease | SpringerLink
Zoltan Dr. Lantos - Head of Department, Department of Virtual Health Guide Methodology - Semmelweis University Faculty of Health Sciences | LinkedIn
![POR | Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor POR | Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor](https://www.por-journal.com/files/Articles/1609926/pore-27-1609926-HTML-r3/image_m/pore-27-1609926-g001.jpg)
POR | Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor
![Magdolna DR. PÓCZI | Head of Department | Dr. Kenessey Albert Hospital, Rákócziújfalu | KENESSEY | Pulmonological department Magdolna DR. PÓCZI | Head of Department | Dr. Kenessey Albert Hospital, Rákócziújfalu | KENESSEY | Pulmonological department](https://i1.rgstatic.net/ii/profile.image/961280349306880-1606198503045_Q128/Magdolna-Dr-Poczi.jpg)
Magdolna DR. PÓCZI | Head of Department | Dr. Kenessey Albert Hospital, Rákócziújfalu | KENESSEY | Pulmonological department
![Márta LADÁNYI | Head of Department | PhD Habil | Institute of Mathematics and Basic Science Dpt. of Applied Statistics Márta LADÁNYI | Head of Department | PhD Habil | Institute of Mathematics and Basic Science Dpt. of Applied Statistics](https://i1.rgstatic.net/ii/profile.image/272814078951436-1442055353238_Q512/Marta-Ladanyi.jpg)
Márta LADÁNYI | Head of Department | PhD Habil | Institute of Mathematics and Basic Science Dpt. of Applied Statistics
Dr. Radeczky Éva Intézményünk allergológus szakorvosa egy rövid videóban beszél az idei allergiaszezon legfontosabb tudnivalóiról. Hasznos információk,... | By Százhalom Egészségügyi Központ | Facebook
![Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2101606901/2080045540/gr1.gif)